fenoldopam has been researched along with Insulin Resistance in 2 studies
Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.
Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fenoldopam treatment significantly increased urine output as well as urinary sodium indicating reduced sodium retention." | 5.32 | Fenoldopam treatment improves peripheral insulin sensitivity and renal function in STZ-induced type 2 diabetic rats. ( Goyal, RK; Umrani, DN, 2003) |
| " Previous studies showed that dopamine D1-like receptor agonists, such as fenoldopam, could improve peripheral insulin sensitivity, while antipsychotics, which are dopamine receptor antagonists, increased susceptibility to Type 2 diabetes mellitus (T2DM)." | 4.31 | Exercise ameliorates skeletal muscle insulin resistance by modulating GRK4-mediated D1R expression. ( Chen, C; Chen, K; Chen, S; Chen, Y; Li, X; Luo, W; Tao, Y; Zeng, C, 2023) |
| "Fenoldopam treatment significantly increased urine output as well as urinary sodium indicating reduced sodium retention." | 1.32 | Fenoldopam treatment improves peripheral insulin sensitivity and renal function in STZ-induced type 2 diabetic rats. ( Goyal, RK; Umrani, DN, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tao, Y | 1 |
| Luo, W | 1 |
| Chen, Y | 1 |
| Chen, C | 1 |
| Chen, S | 1 |
| Li, X | 1 |
| Chen, K | 1 |
| Zeng, C | 1 |
| Umrani, DN | 1 |
| Goyal, RK | 1 |
2 other studies available for fenoldopam and Insulin Resistance
| Article | Year |
|---|---|
Exercise ameliorates skeletal muscle insulin resistance by modulating GRK4-mediated D1R expression.
Topics: Animals; Diabetes Mellitus, Type 2; Fenoldopam; Insulin; Insulin Resistance; Mice; Muscle, Skeletal; | 2023 |
Fenoldopam treatment improves peripheral insulin sensitivity and renal function in STZ-induced type 2 diabetic rats.
Topics: Animals; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; | 2003 |